Market Tracker

05/27 5:16pm ET

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

52.28
Delayed Data
As of 4:00pm ET
 +0.63 / +1.22%
Today’s Change
26.80
Today|||52-Week Range
73.54
+15.86%
Year-to-Date
The Medicines Co. Carbavance TANGO 1 Study Enrolled
3:18pm / Zacks.com - Paid Partner Content
Innocoll Stock Gains on Favorable Phase III Data on Xaracoll
May 26 / Zacks.com - Paid Partner Content
Will ANI Pharmaceuticals (ANIP) Continue to Surge Higher?
9:54am / Zacks.com - Paid Partner Content
Alnylam Pharmaceuticals (ALNY) in Focus: Stock Rises 9.9%
May 26 / Zacks.com - Paid Partner Content
Flexion (FLXN) Zilretta Gets Positive FDA Guidance; Stock Up
8:51am / Zacks.com - Paid Partner Content
Galapagos' RA Drug Filgotinib to Enter Phase III in 3Q16
May 25 / Zacks.com - Paid Partner Content
Baxalta Reports Positive Phase I Study Data on BAX 930
May 26 / Zacks.com - Paid Partner Content
Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta
May 25 / Zacks.com - Paid Partner Content
Alkermes Begins Phase I Study on Immuno-Oncology Drug
May 26 / Zacks.com - Paid Partner Content
Zacks.com featured expert Kevin Matras highlights: ANI Pharmaceuticals, KCG Holdings,...
May 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close51.65
Today’s open51.80
Day’s range51.22 - 52.88
Volume111,659
Average volume (3 months)224,422
Market cap$575.7M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-49.03%
Earnings growth (this year)+34.80%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+36.36%
P/E ratio49.1
Price/Sales6.83
Price/Book3.60

Competitors

 Today’s
change
Today’s
% change
NKNantKwest Inc+0.24+3.35%
RTRXRetrophin Inc+0.25+1.45%
ATRAAtara Biotherapeutic...+0.17+0.98%
FMIFoundation Medicine ...+0.22+1.20%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 1, 2016
EPS forecast (this quarter)$0.80
Annual revenue (last year)$76.3M
Annual profit (last year)$15.3M
Net profit margin20.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur S. Przybyl
Vice President-
Operations
James G. Marken
Corporate headquarters
Baudette, Minnesota

Forecasts